Crispr Therapeutics shares owned by Alpha DNA Investment Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Alpha DNA Investment Management
from 13F filings
Historical chart of Alpha DNA Investment Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Alpha DNA Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Alpha DNA Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $494k | 7.9k | 62.60 |
More positions owned by Alpha DNA Investment Management
View all positions for Alpha DNA Investment Management